Skip to content
JLM-BioCity
  • HOME
  • ABOUT US
    • What is JLM-BioCity?
    • What We Do
    • Board of Advisors
    • Meet the Team
  • EVENTS
    • Past Events
    • Event Clips
  • RESOURCES
    • JLM BIO INNOVATION
    • JLM COMPANIES
    • JLM LANDSCAPE
    • BIOTIPS
    • BLOG
    • BRIEFS
  • JOIN US
    • Our Partners
    • Become a Partner
  • JLM-BIOSYNERGY
  • CONTACT US
Menu Close
  • HOME
  • ABOUT US
    • What is JLM-BioCity?
    • What We Do
    • Board of Advisors
    • Meet the Team
  • EVENTS
    • Past Events
    • Event Clips
  • RESOURCES
    • JLM BIO INNOVATION
    • JLM COMPANIES
    • JLM LANDSCAPE
    • BIOTIPS
    • BLOG
    • BRIEFS
  • JOIN US
    • Our Partners
    • Become a Partner
  • JLM-BIOSYNERGY
  • CONTACT US

JLM-BioCity Innovations

  1. Home>
  2. Resources>
  3. JLM-BioCity Innovations>
  4. Page 27
JLM-Biocity Biotech diagnostics oncology cancer

NovellusDx Inks Japan Distribution Deal for Cancer Treatment Response Assay

September 21, 2018

NovellusDx said today that it has signed a deal with Primetech to distribute its u Functional Annotation for Cancer Treatment (FACT) assay in Japan. NovellusDx brings

Read More »
JLM-BioCity Biomed Diagnostics

Sight Diagnostics Offers an AI-based Diagnostics Device for Faster Blood Tests

August 25, 2018

Sight Diagnostics, an Israeli medical devices startup in Jerusalem that’s using computer vision and machine learning technology to speed up blood testing, is launching a

Read More »
JLM-BioCity Biomed Mental Health patient engegement

Behavioral Health Care Management Startup Valera Health adds Eau Claire Group Health Cooperative to Customer Base

August 25, 2018

Valera Health, a behavioral healthcare management startup that developed an app to help clinicians remotely monitor patients with anxiety and depression,  added Wisconsin health maintenance

Read More »
JLM-BioCity Biomed

NovaSight diagnoses and treats Lazy Eye and Concentration Problems by Monitoring Eye Movement

August 25, 2018

NovaSight system diagnoses eye problems in children and makes it possible to train the eyes in cases of amblyopia (lazy eye) and convergence insufficiency (CI). The

Read More »
JLM-BioCity Biomed

BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive Compulsive Disorder

August 21, 2018

This clearance marks the second indication granted for BrainsWay Deep TMS. The first clearance was for treatment of Major Depressive Disorder in 2013 August 19,

Read More »

US Patent Office Grants NOVELLUSDX Patent for Methods & Systems for identifying Patient-Specific Driver Mutations

August 20, 2018

NovellusDx, the leader in functional genomics, was granted from the US Patenet Office a new patent titled “METHODS AND SYSTEMS FOR IDENTIFYING PATIENT SPECIFIC DRIVER

Read More »
JLM-BioCity Biomed Flu Vaccine

BiondVax receives second €6M tranche disbursement from the European Investment Bank (EIB)

August 20, 2018

BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), developer of M‑001, a clinical phase 3 Universal Influenza Vaccine candidate, recently  announced the receipt of a €6 million disbursement

Read More »
JLM-BioCity Biomed Breast cancer

MonitHer ‘s New Home-Use Breast Cancer Detection Device Wins WeWork’s $360 K Creator Award

August 5, 2018

While Yehudit Abrams was working as a postdoctoral fellow at NASA, her job was to research the potential use of ultrasound to monitor astronauts on

Read More »
JLM-BioCity Biomed Neuroscience AI

Analytics Insights Selected BrainQ as One of the 10 Most Innovative Artificial Intelligence Solution Providers for 2018

August 5, 2018

Analytics Insight announced in their June digital magazine of that BrainQ is one of the most Innovative AI solution providers for 2018. Analytics Insight is

Read More »
« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27 Page28 Page29 Page30 Page31 Page32 Page33 Page34 Page35 Page36 Page37 Page38 Page39 Next »

JLM-BioCity Upcoming Events

JLM-BioCity-&-Columbia-Mission-2022a
To RSVP, contact Sara Gdanski, JLM-BioCity Corporate Relations Manager at 058-7922882
or email her at: sara.gdanski1 AT gmail.com

More JLM BioCity events coming soon…

What people are saying…

Moshe Lebowitz with Jerusalem Mayor Moshe Leon - Credit Dr George Lowell

Because every biotech and medtech professional knows that Jerusalem BioCity consistently delivers world-class programming, the best professionals always show up and the networking before and after the events is worth its time in gold.

- Moshe Lebowitz, CEO, Healables Digital Health | Healables: Wearables that Heal

Ian Solomon CTO, OmnySense Ltd

The JLM Biocity networking events on Zoom keeps getting better.  For OmnySense they have provided an excellent forum in which to present our company, and the break-out sessions facilitate direct discussion with a broad range of potential partners and investors.

- Ian Solomon CTO, OmnySense Ltd.

Dror Chevion Concenter BioPharma

JLM-BioCity's events are well organized with a professional approach. You can feel a "homey" atmosphere around the people of a well-maintained bio-community in Jerusalem. Team members always make sure the guests feel welcome and connected to the right people for possible collaborations. There are clearly visible good-will and dedication to lead the members of the bio-community and the city as a whole to success.

- Dror Chevion CEO, Concenter BioPharma

Immanuel Lerner CEO, Pepticom

I believe in the idea of JLM-BioCity. It is good that there is an organization that represents the life science companies in Jerusalem and provides an excellent platform for networking through its regular meetings.

- Immanuel Lerner CEO, Pepticom

JLM BioCity Member Gideon Silberman

Excellent event. Good speakers, interesting audience. Well done!

- Gideon Silberman, Director of Business Development, Partner and Co-Founder, Aneeva.com

JLM-BioCity member Zeev Malyutin

Thank you all for the great evening, it was a pleasure to see such a good and diverse set of Biomed minded people in Jerusalem!

- Zeev Malyutin, Protein Department Head, Merck KGaA

JLM-BioCity member Aurélie Schwarzbach

Such an interesting lecture and great people attending!

- Aurélie Schwarzbach, Clinical Project Manager, Gamida Cell Ltd.

JLM-BioCity member Jonathan Miller

Interesting - I could see it helping people network - a good thing!

- Jonathan Miller, Founder, President, and Designer, U-Step, Neurological Walking Aids

JLM BioCity Member Yael Ophir

Great atmosphere, great people.

- Yael Ophir, Executive Director, HealthIL

JLM BioCity Member Aviv Marom

There was an excellent networking atmosphere with impressive Panelists as well as high-quality audience participants. I strongly recommend paying attention to future events.

Aviv Marom, Director, Strategic Partnerships, Samsung Research, Israel

JLM BioCity Member Hemda Idel

Very informative and eye-opening event. Thank you for the great hospitality.

- Hemda Idel, founder, SLEEP ASAP

JLM-BioCity Member Tal Or

one of the best meetups organizations and a very important source of information and connections for startups.

Tal Or, Co-Founder, ATLASense Biomed Ltd.

JLM-BioCity Member Alexander Naslednikov

Excellent organization (from the timing to food), the quality of the audience was superior, we personally got a lot of hot leads.

Alexander Naslednikov, Founder and CEO, Med.me

<< Prev
Next >>

JLM-BioCity in THE MARKER

JLM-BioCity was recently written up in THE MARKER (in Hebrew). To see the article, click here.

Strategic Partners

Platinum

Gold

Silver

JLM-BIOCITY is a division of the Jerusalem Business Networking Forum (JBNF)

Contact us at

+972-(0)54-973-0029

info at jlm-biocity.org

Follow us

Linkedin Facebook-f Youtube

Home

About

What’s Happening

Resources

Become a Partner

Become a Member

JLM-BioSynergy

Contact Us

Copyright © 2020 JLM-BioCity | All rights reserved